Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Other Operating Expenses (2016 - 2024)

Historic Other Operating Expenses for ProPhase Labs (PRPH) over the last 15 years, with Q4 2024 value amounting to -$6000.0.

  • ProPhase Labs' Other Operating Expenses changed N/A to -$6000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was -$6000.0, marking a year-over-year change of. This contributed to the annual value of -$6000.0 for FY2024, which is 10031.06% down from last year.
  • As of Q4 2024, ProPhase Labs' Other Operating Expenses stood at -$6000.0.
  • In the past 5 years, ProPhase Labs' Other Operating Expenses ranged from a high of $10.6 million in Q4 2021 and a low of -$4.0 million during Q3 2021
  • In the last 5 years, ProPhase Labs' Other Operating Expenses had a median value of $1.0 million in 2021 and averaged $1.6 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first tumbled by 105227.27% in 2020, then soared by 94240.25% in 2021.
  • Over the past 5 years, ProPhase Labs' Other Operating Expenses (Quarter) stood at -$1.3 million in 2020, then surged by 942.4% to $10.6 million in 2021, then tumbled by 70.68% to $3.1 million in 2022, then crashed by 95.75% to $132000.0 in 2023, then crashed by 104.55% to -$6000.0 in 2024.
  • Its Other Operating Expenses stands at -$6000.0 for Q4 2024, versus $132000.0 for Q3 2023 and $597000.0 for Q2 2023.